Skip to main content
FinSpry Logo
FinSpry
BBNX logo
BBNX
(NASDAQ)
Beta Bionics, Inc.
$9.93-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Beta Bionics (BBNX) Stock Price & Financial Analysis

Beta Bionics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.69 - $10.28
52-Week High$32.71
52-Week Low$8.89
Open$9.81
Volume611.99K
Average Volume (3M)611.99K
Market Cap402.45M
Shares Outstanding40.53M
Price to Sales (P/S)4.05
Price to Book (P/B)1.41
EV/EBITDA-5.55
Revenue (TTM)100.25M
Net Income (TTM)-73.20M
Free Cash Flow (TTM)-45.69M
EPS (TTM)$-1.81
Profit Margin-73.02%
Operating Margin-71.50%
Return on Equity (ROE)-25.45%
Debt to Equity0.03
50-Day MA$12.64
200-Day MA$19.55
52-Week Change-10.94%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Beta Bionics

What is the current stock price for BBNX?

As of the latest trading session, BBNX stock trades at $9.93. The 52-week range is $8.89–$32.71, with a day range of $9.69–$10.28.

What is the P/E ratio for BBNX?

The P/E ratio (Price-to-Earnings) for BBNX is shown in the Key Statistics section. This valuation metric helps compare Beta Bionics, Inc. to industry peers.

Does BBNX pay dividends?

Beta Bionics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BBNX?

Based on 10 analysts, the consensus for BBNX is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BBNX?

Beta Bionics's market capitalization is $402.5M, classifying it as a small-cap company. Beta Bionics operates in the Healthcare sector within the Medical Devices industry.